These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25240404)
1. Rethinking the therapeutic misconception: social justice, patient advocacy, and cancer clinical trial recruitment in the US safety net. Burke NJ BMC Med Ethics; 2014 Sep; 15():68. PubMed ID: 25240404 [TBL] [Abstract][Full Text] [Related]
2. Procedures of recruiting, obtaining informed consent, and compensating research participants in Qatar: findings from a qualitative investigation. Killawi A; Khidir A; Elnashar M; Abdelrahim H; Hammoud M; Elliott H; Thurston M; Asad H; Al-Khal AL; Fetters MD BMC Med Ethics; 2014 Feb; 15():9. PubMed ID: 24495499 [TBL] [Abstract][Full Text] [Related]
3. Accessing health services through the back door: a qualitative interview study investigating reasons why people participate in health research in Canada. Townsend A; Cox SM BMC Med Ethics; 2013 Oct; 14():40. PubMed ID: 24119203 [TBL] [Abstract][Full Text] [Related]
4. Phase 3 Oncology Clinical Trials in South Africa: Experimentation or Therapeutic Misconception? Malan T; Moodley K J Empir Res Hum Res Ethics; 2016 Feb; 11(1):47-56. PubMed ID: 27106890 [TBL] [Abstract][Full Text] [Related]
5. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient. Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549 [TBL] [Abstract][Full Text] [Related]
7. "I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa. Masiye F; Mayosi B; de Vries J BMC Med Ethics; 2017 Feb; 18(1):12. PubMed ID: 28202021 [TBL] [Abstract][Full Text] [Related]
8. Power Difference and Risk Perception: Mapping Vulnerability within the Decision Process of Pregnant Women towards Clinical Trial Participation in an Urban Middle-Income Setting. Den Hollander GC; Browne JL; Arhinful D; van der Graaf R; Klipstein-Grobusch K Dev World Bioeth; 2018 Jun; 18(2):68-75. PubMed ID: 27761986 [TBL] [Abstract][Full Text] [Related]
9. Unrealistic optimism and the ethics of phase I cancer research. Crites J; Kodish E J Med Ethics; 2013 Jun; 39(6):403-6. PubMed ID: 23118468 [TBL] [Abstract][Full Text] [Related]
10. Presuming patient autonomy in the face of therapeutic misconception. McConville P Bioethics; 2017 Nov; 31(9):711-715. PubMed ID: 28857220 [TBL] [Abstract][Full Text] [Related]
11. Informed Consent in Two Alzheimer's Disease Research Centers: Insights From Research Coordinators. Suver CM; Hamann JK; Chin EM; Goldstein FC; Blazel HM; Manzanares CM; Doerr MJ; Asthana SJ; Mangravite LM; Levey AI; Lah JJ; Edwards DF AJOB Empir Bioeth; 2020; 11(2):114-124. PubMed ID: 32175821 [No Abstract] [Full Text] [Related]
12. Ethical issues in research involving minority populations: the process and outcomes of protocol review by the Ethics Committee of the Faculty of Tropical Medicine, Mahidol University, Thailand. Adams P; Wongwit W; Pengsaa K; Khusmith S; Fungladda W; Chaiyaphan W; Limphattharacharoen C; Prakobtham S; Kaewkungwal J BMC Med Ethics; 2013 Sep; 14():33. PubMed ID: 24025591 [TBL] [Abstract][Full Text] [Related]
13. Why take part in personalised cancer research? Patients' genetic misconception, genetic responsibility and incomprehension of stratification-an empirical-ethical examination. Perry J; Wöhlke S; Heßling AC; Schicktanz S Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27507437 [TBL] [Abstract][Full Text] [Related]
14. Dealing with Misconception in Biomedical Research. Perry J; Wöhlke S J Empir Res Hum Res Ethics; 2019 Dec; 14(5):428-432. PubMed ID: 31779559 [No Abstract] [Full Text] [Related]
15. Therapeutic appropriation: a new concept in the ethics of clinical research. McDougall R; Martin D; Gillam L; Hallowell N; Brookes A; Guillemin M J Med Ethics; 2016 Dec; 42(12):805-808. PubMed ID: 27733438 [TBL] [Abstract][Full Text] [Related]
16. Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting. Abernethy ER; Campbell GP; Hianik RS; Thomson MC; Blee SM; Sibold HC; Dixon MD; Switchenko JM; Pentz RD Cancer; 2021 Oct; 127(20):3794-3800. PubMed ID: 34161615 [TBL] [Abstract][Full Text] [Related]
17. Why is therapeutic misconception so prevalent? Lidz CW; Albert K; Appelbaum P; Dunn LB; Overton E; Pivovarova E Camb Q Healthc Ethics; 2015 Apr; 24(2):231-41. PubMed ID: 25719358 [TBL] [Abstract][Full Text] [Related]
18. Additional thoughts on rethinking research ethics. Sharp RR; Yarborough M Am J Bioeth; 2005; 5(1):40-2; author reply W15-8. PubMed ID: 16036657 [No Abstract] [Full Text] [Related]
20. Application of the rapid ethical assessment approach to enhance the ethical conduct of longitudinal population based female cancer research in an urban setting in Ethiopia. Gebremariam A; Yalew AW; Hirpa S; Wondimagegnehu A; Kaba M; Assefa M; Mitiku I; Kantelhardt EJ; Jemal A; Addissie A BMC Med Ethics; 2018 Nov; 19(1):87. PubMed ID: 30428895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]